98 results
Page 3 of 5
8-K
EX-99.1
7q2 ler7za2
13 Jan 20
Regulation FD Disclosure
9:01am
8-K
EX-99.1
99ac vb7z
23 Dec 19
Fibrogen Submits New Drug Application to the U.S. Fda for Roxadustat In Patients with Anemia of Chronic Kidney Disease
9:06am
CORRESP
e7sr t3m9
13 Dec 19
Correspondence with SEC
12:00am
8-K
EX-99.2
aem 9ex9rz87dywu
12 Nov 19
FibroGen Reports Third Quarter 2019 Financial Results
8:16am
8-K
EX-99.1
v69dhmwppj5p 2kye
8 Nov 19
Regulation FD Disclosure
2:05pm
8-K
EX-99.1
mojx9x0c3o9semkboau
8 Nov 19
FibroGen Announces Positive Phase 3 Pooled Roxadustat Safety and Efficacy Results for Treatment of Anemia in Chronic Kidney Disease
2:00pm
8-K
EX-99.1
h7z7mw
11 Oct 19
Regulation FD Disclosure
11:49am
8-K
EX-99.1
yjmooybve p875
26 Sep 19
FibroGen Announces Initiation of Phase 2 Clinical Trial of Roxadustat for the Treatment
9:01am
8-K
EX-99.1
mc0gq daz0b7nio66e
28 Jun 19
Regulation FD Disclosure
9:01am
8-K
EX-99.1
9vwj4zu1
15 Apr 19
Other Events
9:00am
8-K
EX-99.1
imhz5ym j7lbv
20 Dec 18
FibroGen Announces Positive Topline Results from Three Global Phase 3
8:30am
8-K
EX-99.1
hzj pc6a7ezwzx
7 Jun 18
Other Events
7:31am